<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | McFadden Connell | Activity</title>
	<link>https://www.catswannabecats.com/members/stageturtle1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/stageturtle1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for McFadden Connell.</description>
	<lastBuildDate>Wed, 10 Jun 2026 16:30:16 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4f95e87b092d3acefc260a2455836773</guid>
				<title>McFadden Connell posted an update: More than half of patients undergoing percutaneous coronary [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26704/</link>
				<pubDate>Tue, 10 Jun 2025 14:02:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>More than half of patients undergoing percutaneous coronary intervention (PCI) have multivessel disease (MVD). The prognostic significance of PCI in stable patients has recently been debated, but little data exists about the potential benefit of complete revascularization (CR) in stable MVD. We investigated the prognostic benefit of CR in patients&hellip;<span class="activity-read-more" id="activity-read-more-26704"><a href="https://www.catswannabecats.com/activity/p/26704/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b12ee6223f32c7dcc5ced14f7c696957</guid>
				<title>McFadden Connell posted an update: More than half of patients undergoing percutaneous coronary [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26622/</link>
				<pubDate>Tue, 10 Jun 2025 13:50:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>More than half of patients undergoing percutaneous coronary intervention (PCI) have multivessel disease (MVD). The prognostic significance of PCI in stable patients has recently been debated, but little data exists about the potential benefit of complete revascularization (CR) in stable MVD. We investigated the prognostic benefit of CR in patients&hellip;<span class="activity-read-more" id="activity-read-more-26622"><a href="https://www.catswannabecats.com/activity/p/26622/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c64a3375b57973902d3c86410d8bc259</guid>
				<title>McFadden Connell posted an update: 3 cm and 31.8% were Transatlantic Inter-Society Consensus II [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26189/</link>
				<pubDate>Mon, 09 Jun 2025 13:56:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>3 cm and 31.8% were Transatlantic Inter-Society Consensus II C/D lesions. The overall technical success rate of the 1269 drug-coated balloon (DCB)&#8217;s used was 99.6% (1.60 ± 0.79 DCB&#8217;s/patient). At 12 months, the TLR rates were 6.3% in patients with CLI and 9.6% in claudicants, with a primary patency rate of 89.9% and 87.1%, respectively. All-cause&hellip;<span class="activity-read-more" id="activity-read-more-26189"><a href="https://www.catswannabecats.com/activity/p/26189/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">01c6afe78d4f6f10b7028e0b65070cb4</guid>
				<title>McFadden Connell posted an update: Endothelial cell (EC) dysfunction contributes to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24909/</link>
				<pubDate>Sun, 08 Jun 2025 13:59:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>Endothelial cell (EC) dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy, and the angiotensin-converting enzyme 2 (ACE2) receptor plays a role in EC dysfunction in COVID-19. To expand the understanding of the role of the ACE2 receptor relative to EC dysfunction, this review addresses (1) tissue distribution of&hellip;<span class="activity-read-more" id="activity-read-more-24909"><a href="https://www.catswannabecats.com/activity/p/24909/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05f2a6b81ddafae5e1e8c0054b667238</guid>
				<title>McFadden Connell posted an update: The results of this study demonstrate that the degree of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22916/</link>
				<pubDate>Sat, 07 Jun 2025 13:58:16 -0400</pubDate>

									<content:encoded><![CDATA[<p>The results of this study demonstrate that the degree of correction rate does not correlate with the degree of improvement in the SRS-22 questionnaire in patients with AIS that underwent posterior fusion and instrumentation.In the present report, a case of a healthy, 38-year-old male recreational marathon runner who presented in the emergency&hellip;<span class="activity-read-more" id="activity-read-more-22916"><a href="https://www.catswannabecats.com/activity/p/22916/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c8c82889925f623c826ab210db2eeb86</guid>
				<title>McFadden Connell posted an update: The resulting socioeconomic sampling bias limits the scope [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21823/</link>
				<pubDate>Fri, 06 Jun 2025 15:02:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>The resulting socioeconomic sampling bias limits the scope of the technostress model to high SEP occupations. The lack of findings regarding differences by SEP in technostress can partly be attributed to limitations in study designs. <a href="https://www.selleckchem.com/" rel="nofollow ugc">this website</a> Studies should aim to reduce the heterogeneity of technostress and SEP measures to improve external&hellip;<span class="activity-read-more" id="activity-read-more-21823"><a href="https://www.catswannabecats.com/activity/p/21823/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c65821748fe1a8e5f8795f4dc3bc8b90</guid>
				<title>McFadden Connell posted an update: This study presents the electromagnetic (EM) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20618/</link>
				<pubDate>Thu, 05 Jun 2025 14:46:51 -0400</pubDate>

									<content:encoded><![CDATA[<p>This study presents the electromagnetic (EM) characterization of a multiwalled carbon nanotubes (MWCNT)-silver nanoparticles (AgNP)-reinforced poly(vinyl alcohol) (PVA) hybrid nanocomposite fabricated via the solution mixing technique. Primarily, the structure and morphological properties of the PVA/MWCNT-AgNP hybrid nanocomposite are confirmed by&hellip;<span class="activity-read-more" id="activity-read-more-20618"><a href="https://www.catswannabecats.com/activity/p/20618/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1149391db2ac1c001ebbbca0c770d272</guid>
				<title>McFadden Connell posted an update: Infection and insufficient osteointegration are the main [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19320/</link>
				<pubDate>Wed, 04 Jun 2025 13:25:17 -0400</pubDate>

									<content:encoded><![CDATA[<p>Infection and insufficient osteointegration are the main causes of orthopedic implant failure. Furthermore, activating favorable inflammation response is vital to the fast osteointegration of implants. Therefore, endowing the implants with multifunctions (antibacterial, anti-inflammation, and pro-osteointegration) is a promising strategy to&hellip;<span class="activity-read-more" id="activity-read-more-19320"><a href="https://www.catswannabecats.com/activity/p/19320/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ee67d4ab7d777599259046cd43488698</guid>
				<title>McFadden Connell posted an update: The median PFS was 8 months (range 0-57), and the median O [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18230/</link>
				<pubDate>Tue, 03 Jun 2025 13:02:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>The median PFS was 8 months (range 0-57), and the median OS was 15 months (range 0-71). Tailored BRAFi ± MEKi treatment for older patients is feasible. Adverse effects occur frequently but are manageable by dose adjustment. The occurrence of toxicity of monotherapy was similar to that of combination therapy. The RR and median OS from our retrospe&hellip;<span class="activity-read-more" id="activity-read-more-18230"><a href="https://www.catswannabecats.com/activity/p/18230/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d806139378b481fe68c2670fbc0c86d5</guid>
				<title>McFadden Connell posted an update: The disruption of the immune tolerance induces autoimmunity [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/15316/</link>
				<pubDate>Mon, 02 Jun 2025 14:36:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>The disruption of the immune tolerance induces autoimmunity such as systemic lupus erythematosus and vasculitis. A chromatin-binding non-histone protein, high mobility group box 1 (HMGB1), is released from the nucleus to the extracellular milieu in particular environments such as autoimmunity, sepsis and hypoxia. Extracellular HMGB1 engages&hellip;<span class="activity-read-more" id="activity-read-more-15316"><a href="https://www.catswannabecats.com/activity/p/15316/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b54f3dfc272e7548f46dcb2c3d20872e</guid>
				<title>McFadden Connell posted an update: Vitamin D should be administered daily until adequate levels [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12993/</link>
				<pubDate>Sun, 01 Jun 2025 14:09:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>Vitamin D should be administered daily until adequate levels are achieved due to vitamin D behaves as a negative acute phase reactant (APR). Despite the lack of evidence on specific doses of vitamin D to treat COVID-19 in older adults, authors consider it is necessary to standardize the use in clinical practice. These recommendations advice&hellip;<span class="activity-read-more" id="activity-read-more-12993"><a href="https://www.catswannabecats.com/activity/p/12993/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7c77b8948f91bfa13ff018b6050d9c52</guid>
				<title>McFadden Connell became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/6053/</link>
				<pubDate>Sat, 31 May 2025 15:44:46 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>